Page last updated: 2024-10-26

2-amino-7-phosphonoheptanoic acid and Infarction, Middle Cerebral Artery

2-amino-7-phosphonoheptanoic acid has been researched along with Infarction, Middle Cerebral Artery in 1 studies

2-amino-7-phosphonoheptanoic acid: (D)-isomer active as an antagonist of N-methyl-D-aspartate excitation of central neurons; (L)-isomer inactive; RN given refers to cpd without isomeric designation

Infarction, Middle Cerebral Artery: NECROSIS occurring in the MIDDLE CEREBRAL ARTERY distribution system which brings blood to the entire lateral aspects of each CEREBRAL HEMISPHERE. Clinical signs include impaired cognition; APHASIA; AGRAPHIA; weak and numbness in the face and arms, contralaterally or bilaterally depending on the infarction.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baudy, RB1
Fletcher, H1
Yardley, JP1
Zaleska, MM1
Bramlett, DR1
Tasse, RP1
Kowal, DM1
Katz, AH1
Moyer, JA1
Abou-Gharbia, M1

Other Studies

1 other study available for 2-amino-7-phosphonoheptanoic acid and Infarction, Middle Cerebral Artery

ArticleYear
Design, synthesis, SAR, and biological evaluation of highly potent benzimidazole-spaced phosphono-alpha-amino acid competitive NMDA antagonists of the AP-6 type.
    Journal of medicinal chemistry, 2001, May-10, Volume: 44, Issue:10

    Topics: Animals; Arterial Occlusive Diseases; Benzimidazoles; Binding, Competitive; Brain; Carotid Artery Di

2001